Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.240
-0.070 (-2.11%)
At close: Jul 25, 2025, 4:00 PM
3.260
+0.020 (0.62%)
After-hours: Jul 25, 2025, 7:27 PM EDT

Voyager Therapeutics Revenue

Voyager Therapeutics had revenue of $6.47M in the quarter ending March 31, 2025, a decrease of -66.83%. This brings the company's revenue in the last twelve months to $66.96M, down -43.75% year-over-year. In the year 2024, Voyager Therapeutics had annual revenue of $80.00M, down -68.00%.

Revenue (ttm)
$66.96M
Revenue Growth
-43.75%
P/S Ratio
2.81
Revenue / Employee
$389,291
Employees
172
Market Cap
179.29M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202480.00M-170.01M-68.00%
Dec 31, 2023250.01M209.10M511.16%
Dec 31, 202240.91M3.49M9.33%
Dec 31, 202137.42M-133.71M-78.14%
Dec 31, 2020171.13M66.74M63.93%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.